| Income Statement | 2026-04-30 | |||
|---|---|---|---|---|
| Revenue | 4,319 | |||
| Cost of sales | 1,768 | |||
| Gross margin | 2,551 | |||
| Research and development | 2,839,012 | |||
| Selling, general and administrative | 5,576,406 | |||
| Total operating expenses | 8,415,418 | |||
| Loss from operations | -8,412,867 | |||
| Interest expense | 753,041 | |||
| Other income | 24,033 | |||
| Total other expense | -729,008 | |||
| Net loss | -9,141,875 | |||
| Basic EPS | -3.48 | |||
| Basic Average Shares | 2,625,421 | |||
HeartSciences Inc. (HSCSW)
HeartSciences Inc. (HSCSW)